These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1359767)

  • 21. [Prevalence of HIV antigens in cerebrospinal fluid and in serum of patients with both asymptomatic and symptomatic HIV infection].
    Radkowski M; Laskus T; Kopicz-Kamińska E; Mian M; Babiuch L; Slusarczyk J
    Pol Tyg Lek; 1992 Sep 7-14; 47(36-37):784-6. PubMed ID: 1293560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study.
    Robert-Guroff M; Goedert JJ; Naugle CJ; Jennings AM; Blattner WA; Gallo RC
    AIDS Res Hum Retroviruses; 1988 Oct; 4(5):343-50. PubMed ID: 3196490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing antibodies and the course of HIV-induced disease.
    Wendler I; Bienzle U; Hunsmann G
    AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the serologic profile of children with human immunodeficiency virus infection: correlation with clinical status.
    Kamani N; Krilov LR; Wittek AE; Hendry RM
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):233-42. PubMed ID: 2791340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease.
    Füst G; Tóth FD; Kiss J; Ujhelyi E; Nagy I; Bánhegyi D
    AIDS; 1994 May; 8(5):603-9. PubMed ID: 7914732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of serum neutralization response to the human immunodeficiency virus (HIV).
    Groopman JE; Benz PM; Ferriani R; Mayer K; Allan JD; Weymouth LA
    AIDS Res Hum Retroviruses; 1987; 3(1):71-85. PubMed ID: 2441727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.
    Broliden K; Sievers E; Tovo PA; Moschese V; Scarlatti G; Broliden PA; Fundaro C; Rossi P
    Clin Exp Immunol; 1993 Jul; 93(1):56-64. PubMed ID: 8324904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody.
    Gupta P; Balachandran R; Ho M; Enrico A; Rinaldo C
    J Virol; 1989 May; 63(5):2361-5. PubMed ID: 2704079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group.
    Montefiori DC; Lefkowitz LB; Keller RE; Holmberg V; Sandstrom E; Phair JP
    AIDS; 1991 May; 5(5):513-7. PubMed ID: 1863402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of human HIV type 1 neutralizing reference sera.
    Vujcic LK; Quinnan GV
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):783-7. PubMed ID: 7546904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals.
    Homsy J; Meyer M; Levy JA
    J Virol; 1990 Apr; 64(4):1437-40. PubMed ID: 2319642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing antibody and clinical status of human immunodeficiency virus (HIV)-infected individuals.
    Alesi DR; Ajello F; Lupo G; Vitale F; Portera M; Spadaro F; Romano N
    J Med Virol; 1989 Jan; 27(1):7-12. PubMed ID: 2784162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers.
    Ljunggren K; Moschese V; Broliden PA; Giaquinto C; Quinti I; Fenyö EM; Wahren B; Rossi P; Jondal M
    J Infect Dis; 1990 Feb; 161(2):198-202. PubMed ID: 2299204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.
    Reiss P; Lange JM; de Ronde A; de Wolf F; Dekker J; Debouck C; Goudsmit J
    J Med Virol; 1990 Mar; 30(3):163-8. PubMed ID: 2341832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for anti-AIDS chemotherapy directed at HIV-1 infected dendritic cells in seropositive individuals prior to the appearance of ARC and AIDS.
    Becker Y
    J Chemother; 1990 Jun; 2(3):152-5. PubMed ID: 2143219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV neutralizing antibodies: development and association with HIV related disease.
    Arendrup M; Ulrich K; Nielsen JO; Lindhardt BO; Kusk P; Mathiesen LR; Pedersen C; Krogsgaard K
    Scand J Infect Dis; 1989; 21(1):19-26. PubMed ID: 2727625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlates of protection in HIV infection and the progression of HIV infection to AIDS.
    Clerici M; Shearer GM
    Immunol Lett; 1996 Jun; 51(1-2):69-73. PubMed ID: 8811347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New HIV plaque titration; application to the assay of neutralizing antibody.
    Tsunetsugu-Yokota Y; Ohshima M; Naito A; Chermann JC; Shih J; Yoshikura H
    J Virol Methods; 1993 Jan; 41(1):47-57. PubMed ID: 8432763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies in male homosexuals and HIV infection.
    Argov S; Schattner A; Burstein R; Handzel ZT; Shoenfeld Y; Bentwich Z
    Immunol Lett; 1991 Sep; 30(1):31-5. PubMed ID: 1959941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A report on 8 seronegative converted HIV/AIDS patients with traditional Chinese medicine].
    Lu WB; Wen RX; Guan CF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 May; 17(5):271-3. PubMed ID: 9863108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.